Annual SGA
$120.00 M
+$3.00 M+2.56%
December 31, 2024
Summary
- As of March 9, 2025, RCUS annual SGA is $120.00 million, with the most recent change of +$3.00 million (+2.56%) on December 31, 2024.
- During the last 3 years, RCUS annual SGA has risen by +$48.00 million (+66.67%).
- RCUS annual SGA is now at all-time high.
Performance
RCUS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$28.00 M
-$2.00 M-6.67%
December 31, 2024
Summary
- As of March 9, 2025, RCUS quarterly SGA is $28.00 million, with the most recent change of -$2.00 million (-6.67%) on December 31, 2024.
- Over the past year, RCUS quarterly SGA has dropped by -$1.00 million (-3.45%).
- RCUS quarterly SGA is now -12.50% below its all-time high of $32.00 million, reached on March 31, 2024.
Performance
RCUS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.97 B
-$283.00 M-7.68%
December 31, 2024
Summary
- As of March 9, 2025, RCUS TTM SGA is -$3.97 billion, with the most recent change of -$283.00 million (-7.68%) on December 31, 2024.
- Over the past year, RCUS TTM SGA has dropped by -$4.09 billion (-3492.31%).
- RCUS TTM SGA is now -5319.61% below its all-time high of -$73.23 million.
Performance
RCUS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RCUS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.6% | -3.5% | -3492.3% |
| 3 y3 years | +66.7% | +21.7% | -5612.5% |
| 5 y5 years | +375.7% | +324.8% | -10000.0% |
RCUS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +66.7% | -12.5% | +21.7% | -164.0% | at low |
| 5 y | 5-year | at high | +375.7% | -12.5% | +324.8% | -468.0% | at low |
| alltime | all time | at high | +2949.6% | -12.5% | +1771.7% | -5319.6% | at low |
Arcus Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $120.00 M(+2.6%) | $28.00 M(-6.7%) | $120.00 M(-0.8%) |
| Sep 2024 | - | $30.00 M(0.0%) | $121.00 M(0.0%) |
| Jun 2024 | - | $30.00 M(-6.3%) | $121.00 M(+1.7%) |
| Mar 2024 | - | $32.00 M(+10.3%) | $119.00 M(+1.7%) |
| Dec 2023 | $117.00 M(+12.5%) | $29.00 M(-3.3%) | $117.00 M(+0.9%) |
| Sep 2023 | - | $30.00 M(+7.1%) | $116.00 M(+3.6%) |
| Jun 2023 | - | $28.00 M(-6.7%) | $112.00 M(+1.8%) |
| Mar 2023 | - | $30.00 M(+7.1%) | $110.00 M(+5.8%) |
| Dec 2022 | $104.00 M(+44.4%) | $28.00 M(+7.7%) | $104.00 M(+5.0%) |
| Sep 2022 | - | $26.00 M(0.0%) | $99.01 M(+10.8%) |
| Jun 2022 | - | $26.00 M(+8.3%) | $89.35 M(+11.4%) |
| Mar 2022 | - | $24.00 M(+4.3%) | $80.18 M(+11.4%) |
| Dec 2021 | $72.00 M(+67.4%) | $23.01 M(+40.8%) | $72.00 M(+15.4%) |
| Sep 2021 | - | $16.34 M(-2.9%) | $62.37 M(+9.0%) |
| Jun 2021 | - | $16.83 M(+6.4%) | $57.21 M(+10.4%) |
| Mar 2021 | - | $15.82 M(+18.2%) | $51.81 M(+20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $43.00 M(+70.4%) | $13.38 M(+19.7%) | $43.00 M(+18.8%) |
| Sep 2020 | - | $11.18 M(-2.2%) | $36.21 M(+10.4%) |
| Jun 2020 | - | $11.43 M(+63.1%) | $32.79 M(+20.2%) |
| Mar 2020 | - | $7.01 M(+6.3%) | $27.27 M(+8.1%) |
| Dec 2019 | $25.23 M(+86.0%) | $6.59 M(-15.0%) | $25.23 M(+13.4%) |
| Sep 2019 | - | $7.76 M(+31.2%) | $22.25 M(+23.1%) |
| Jun 2019 | - | $5.91 M(+19.0%) | $18.07 M(+15.8%) |
| Mar 2019 | - | $4.97 M(+37.6%) | $15.61 M(+15.0%) |
| Dec 2018 | $13.57 M(+77.7%) | $3.61 M(+0.9%) | $13.57 M(+9.4%) |
| Sep 2018 | - | $3.58 M(+3.7%) | $12.40 M(+16.0%) |
| Jun 2018 | - | $3.45 M(+17.8%) | $10.69 M(+17.9%) |
| Mar 2018 | - | $2.93 M(+19.6%) | $9.07 M(+18.8%) |
| Dec 2017 | $7.64 M(+94.1%) | $2.45 M(+31.5%) | $7.64 M(+47.2%) |
| Sep 2017 | - | $1.86 M(+1.7%) | $5.19 M(+56.0%) |
| Jun 2017 | - | $1.83 M(+22.3%) | $3.33 M(+122.3%) |
| Mar 2017 | - | $1.50 M | $1.50 M |
| Dec 2016 | $3.94 M | - | - |
FAQ
- What is Arcus Biosciences annual SGA?
- What is the all time high annual SGA for Arcus Biosciences?
- What is Arcus Biosciences annual SGA year-on-year change?
- What is Arcus Biosciences quarterly SGA?
- What is the all time high quarterly SGA for Arcus Biosciences?
- What is Arcus Biosciences quarterly SGA year-on-year change?
- What is Arcus Biosciences TTM SGA?
- What is the all time high TTM SGA for Arcus Biosciences?
- What is Arcus Biosciences TTM SGA year-on-year change?
What is Arcus Biosciences annual SGA?
The current annual SGA of RCUS is $120.00 M
What is the all time high annual SGA for Arcus Biosciences?
Arcus Biosciences all-time high annual SGA is $120.00 M
What is Arcus Biosciences annual SGA year-on-year change?
Over the past year, RCUS annual SGA has changed by +$3.00 M (+2.56%)
What is Arcus Biosciences quarterly SGA?
The current quarterly SGA of RCUS is $28.00 M
What is the all time high quarterly SGA for Arcus Biosciences?
Arcus Biosciences all-time high quarterly SGA is $32.00 M
What is Arcus Biosciences quarterly SGA year-on-year change?
Over the past year, RCUS quarterly SGA has changed by -$1.00 M (-3.45%)
What is Arcus Biosciences TTM SGA?
The current TTM SGA of RCUS is -$3.97 B
What is the all time high TTM SGA for Arcus Biosciences?
Arcus Biosciences all-time high TTM SGA is -$73.23 M
What is Arcus Biosciences TTM SGA year-on-year change?
Over the past year, RCUS TTM SGA has changed by -$4.09 B (-3492.31%)